Boric Acid

Boric Acid

SCHEMBL3164104

N.N.N.N.OB(O)O.OB(O)O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.80
TSHR P16473 1/20 0.80
TDP1 Q9NUW8 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Boric Acid SCHEMBL9057570 1.00
Boric Acid SCHEMBL50434 1.00 LMNA (0.80) LMNATSHRTDP1
Boric Acid SCHEMBL5147900 1.00 LMNA (0.80) LMNATSHRTDP1
Boric Acid SCHEMBL9057574 1.00 LMNA (0.80) LMNATSHRTDP1
Boric Acid SCHEMBL3057801 1.00 LMNA (0.80) LMNATSHRTDP1
Boric Acid SCHEMBL10823790 1.00 LMNA (0.80) LMNATSHRTDP1
Boric Acid SCHEMBL5147898 1.00
Boric Acid SCHEMBL6002500 1.00 LMNA (0.80) LMNATSHRTDP1
Boric Acid SCHEMBL22390810 1.00 LMNA (0.80) LMNATSHRTDP1
Boric Acid SCHEMBL5706574 1.00 LMNA (0.80) LMNATSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278456-B2 Synthesis and stabilization of neutral compounds with homonuclear bonds UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-10-02 US disclosed
US-20100041895-A1 Synthesis and Stabilization of Neutral Compounds with Homonuclear Bonds UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041895-A1 Synthesis and Stabilization of Neutral Compounds with Homonuclear Bonds NCL, NCLN, NES LMNA 546/4885TSHR 4796/4885TDP1 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.